• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌感染。

Clostridioides difficile Infection.

机构信息

From the Centers for Disease Control and Prevention, Atlanta, Georgia. (A.Y.G., P.K.K.).

出版信息

Ann Intern Med. 2018 Oct 2;169(7):ITC49-ITC64. doi: 10.7326/AITC201810020.

DOI:10.7326/AITC201810020
PMID:30285209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6524133/
Abstract

Clostridioides difficile (formerly Clostridium difficile) infection is the most frequently identified health care-associated infection in the United States. C difficile has also emerged as a cause of community-associated diarrhea, resulting in increased incidence of community-associated infection. Clinical illness ranges in severity from mild diarrhea to fulminant colitis and death. Appropriate management of infection requires understanding of the various diagnostic assays and therapeutic options as well as relevant measures to infection prevention. This article provides updated recommendations regarding the prevention, diagnosis, and treatment of incident and recurrent C difficile infection.

摘要

艰难梭菌(以前称为艰难梭菌)感染是美国最常见的与卫生保健相关的感染。艰难梭菌也已成为社区相关腹泻的病因,导致社区相关感染的发生率增加。临床疾病的严重程度从轻度腹泻到暴发性结肠炎和死亡不等。适当的感染管理需要了解各种诊断检测和治疗选择以及相关的感染预防措施。本文提供了关于新发和复发性艰难梭菌感染的预防、诊断和治疗的最新建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f0/6524133/8481185c7dd8/nihms-1025172-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f0/6524133/8481185c7dd8/nihms-1025172-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f0/6524133/8481185c7dd8/nihms-1025172-f0001.jpg

相似文献

1
Clostridioides difficile Infection.艰难梭菌感染。
Ann Intern Med. 2018 Oct 2;169(7):ITC49-ITC64. doi: 10.7326/AITC201810020.
2
Recent developments in the management of recurrent Clostridioides difficile infection.复发性艰难梭菌感染管理的最新进展。
Anaerobe. 2020 Apr;62:102108. doi: 10.1016/j.anaerobe.2019.102108. Epub 2019 Oct 10.
3
Current Approaches to Treat and Prevent Recurrence of Clostridioides difficile.艰难梭菌治疗与预防复发的当前方法
Gastroenterol Clin North Am. 2025 Jun;54(2):259-275. doi: 10.1016/j.gtc.2025.02.005. Epub 2025 Mar 24.
4
Clostridioides difficile Colitis.艰难梭菌相关性结肠炎。
Surg Clin North Am. 2024 Jun;104(3):545-556. doi: 10.1016/j.suc.2023.11.005. Epub 2023 Dec 26.
5
Clostridioides difficile Infections: Prevention and Treatment Strategies.艰难梭菌感染:预防与治疗策略。
Adv Exp Med Biol. 2024;1449:175-186. doi: 10.1007/978-3-031-58572-2_11.
6
Critical Care Management of the Patient with Clostridioides difficile.艰难梭菌感染患者的重症监护管理。
Crit Care Med. 2021 Jan 1;49(1):127-139. doi: 10.1097/CCM.0000000000004739.
7
A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.艰难梭菌感染与抗生素相关性腹泻综述
Gastroenterol Clin North Am. 2021 Jun;50(2):323-340. doi: 10.1016/j.gtc.2021.02.010.
8
Management of Clostridioides difficile Infection: Diagnosis, Treatment, and Future Perspectives.艰难梭菌感染的管理:诊断、治疗及未来展望
Am J Med. 2024 Jul;137(7):571-576. doi: 10.1016/j.amjmed.2024.03.024. Epub 2024 Mar 18.
9
[Nosocomial gastrointestinal infections and Clostridioides difficile].[医院获得性胃肠道感染与艰难梭菌]
Dtsch Med Wochenschr. 2025 Feb;150(4):149-156. doi: 10.1055/a-2303-3321. Epub 2025 Jan 29.
10
Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.艰难梭菌定植清除与抗生素特异性细菌变化相关。
mSphere. 2021 May 5;6(3):e01238-20. doi: 10.1128/mSphere.01238-20.

引用本文的文献

1
AF6 regulates intestinal IgA via crosstalk between intestinal epithelial cells and immune cells in inflammatory bowel disease.AF6通过炎症性肠病中肠上皮细胞与免疫细胞之间的串扰调节肠道IgA。
iScience. 2025 May 13;28(7):112658. doi: 10.1016/j.isci.2025.112658. eCollection 2025 Jul 18.
2
Clostridioides difficile meets the adenosine system: the art of manipulating host homeostasis.艰难梭菌与腺苷系统:操纵宿主内稳态的技巧
J Biomed Sci. 2025 Jul 11;32(1):66. doi: 10.1186/s12929-025-01160-8.
3
Acute Inflammatory Ascites Complicating Clostridium difficile Colitis.

本文引用的文献

1
Risk Factors for Community-Associated Infection in Adults: A Case-Control Study.成人社区获得性感染的危险因素:一项病例对照研究。
Open Forum Infect Dis. 2017 Oct 26;4(4):ofx171. doi: 10.1093/ofid/ofx171. eCollection 2017 Fall.
2
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).临床实践指南:成人和儿童艰难梭菌感染:美国传染病学会(IDSA)和美国医疗保健流行病学学会(SHEA) 2017 年更新。
Clin Infect Dis. 2018 Mar 19;66(7):e1-e48. doi: 10.1093/cid/cix1085.
3
艰难梭菌结肠炎并发急性炎性腹水
Cureus. 2025 Jun 10;17(6):e85685. doi: 10.7759/cureus.85685. eCollection 2025 Jun.
4
Innovative nucleic acid detection of utilizing the PAM-unconventional, one-step LAMP/CRISPR-Cas12b detection platforms.利用PAM非传统一步式LAMP/CRISPR-Cas12b检测平台进行创新核酸检测。
Front Cell Infect Microbiol. 2025 May 29;15:1594271. doi: 10.3389/fcimb.2025.1594271. eCollection 2025.
5
Evaluation of the Efficacy of UV-C Radiation in Eliminating from Touch Surfaces Under Laboratory Conditions.在实验室条件下评估紫外线C辐射对触摸表面的消毒效果。
Microorganisms. 2025 Apr 25;13(5):986. doi: 10.3390/microorganisms13050986.
6
Bifidobacterium breve synergizes with Akkermansia muciniphila and Bacteroides ovatus to antagonize Clostridioides difficile.短双歧杆菌与嗜黏蛋白阿克曼氏菌和卵形拟杆菌协同作用以拮抗艰难梭菌。
ISME J. 2025 Jan 2;19(1). doi: 10.1093/ismejo/wraf086.
7
The Global Burden of Infections, 2016-2024: A Systematic Review and Meta-Analysis.2016 - 2024年全球感染负担:系统评价与荟萃分析
Infect Dis Rep. 2025 Apr 14;17(2):31. doi: 10.3390/idr17020031.
8
Antibiotic Exposure and Risk of Allograft Rejection and Survival After Liver Transplant: An Observational Cohort Study From a Tertiary Referral Centre.肝移植后抗生素暴露与同种异体移植物排斥反应及生存风险:一项来自三级转诊中心的观察性队列研究
Transpl Infect Dis. 2025 Mar 28;27(3):e70026. doi: 10.1111/tid.70026.
9
Cell Wall Protein 2 as a Vaccine Candidate Protects Mice Against Infection.细胞壁蛋白2作为候选疫苗可保护小鼠免受感染。
Vaccines (Basel). 2024 Dec 30;13(1):21. doi: 10.3390/vaccines13010021.
10
Global burden and trends of the infection-associated diseases from 1990 to 2021: an observational trend study.1990年至2021年感染相关疾病的全球负担及趋势:一项观察性趋势研究
Ann Med. 2025 Dec;57(1):2451762. doi: 10.1080/07853890.2025.2451762. Epub 2025 Jan 23.
Duration of Contact Precautions for Acute-Care Settings.
急性护理环境中接触预防措施的持续时间。
Infect Control Hosp Epidemiol. 2018 Feb;39(2):127-144. doi: 10.1017/ice.2017.245. Epub 2018 Jan 11.
4
Effects of control interventions on Clostridium difficile infection in England: an observational study.英格兰控制干预措施对艰难梭菌感染的影响:一项观察性研究。
Lancet Infect Dis. 2017 Apr;17(4):411-421. doi: 10.1016/S1473-3099(16)30514-X. Epub 2017 Jan 25.
5
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.贝洛妥珠单抗预防复发性艰难梭菌感染。
N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615.
6
Household Transmission of Clostridium difficile to Family Members and Domestic Pets.艰难梭菌在家中向家庭成员和家养宠物的传播。
Infect Control Hosp Epidemiol. 2016 Nov;37(11):1342-1348. doi: 10.1017/ice.2016.178.
7
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.粪便微生物群移植对多次复发性艰难梭菌感染复发的影响:一项随机试验
Ann Intern Med. 2016 Nov 1;165(9):609-616. doi: 10.7326/M16-0271. Epub 2016 Aug 23.
8
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.冷冻与新鲜粪便微生物群移植治疗复发性艰难梭菌感染患者腹泻的临床缓解效果:一项随机临床试验。
JAMA. 2016 Jan 12;315(2):142-9. doi: 10.1001/jama.2015.18098.
9
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection.随机临床试验:结肠镜检查下粪便微生物群移植与万古霉素治疗复发性艰难梭菌感染的比较
Aliment Pharmacol Ther. 2015 May;41(9):835-43. doi: 10.1111/apt.13144. Epub 2015 Mar 1.
10
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.